Skip to main content
News Wilhelm 07.2022
© AG Wilhelm / UKB

News categories: Publication

Covid-19: Immune response hampered by low availability of ketone bodies

Supply of T-cells with adequate energy carriers deficient in patients suffering from Covid-19

In Covid-19 patients, the metabolism produces energy-rich ketone bodies in insufficient amounts. However, these energy carriers are needed by both helper and killer T-cells in order to fight the virus effectively. Perhaps this finding explains why some people become much more seriously ill than others. A study led by ImmunoSensation2 member Prof. Christoph Wilhelm at least points in this direction. The results have now been published in the journal Nature. They also give hope for new therapeutic approaches.

Infections often are accompanied by a loss in appetite. The consequence is a reduced supply with carbohydrates, which induces a metabolic switch towards fat burning. In this, ketone bodies generated from Acetyl-CoA, provide a high energy source, helping our bodies cope better with pathogens.

At least that is what the results of the current study suggest. "We found that patients with viral flu produce ketone bodies in large quantities," explains Prof. Dr. Christoph Wilhelm from the Institute of Clinical Chemistry and Clinical Pharmacology at the University Hospital Bonn. "In contrast, we saw little increase in Covid-19 patients, at least in those with a moderate or severe course."

It was furthermore noticeable that those infected with the coronavirus had lower levels of cytokines in their blood. This was especially true for interferon-gamma, secreted by helper T cells in order to recruit macrophages and further immune cells to the site of infection. For this, however, the helper T cells apparently require an adequate supply of ketone bodies. If this is missing, they produce less interferon-gamma. Moreover, the helper cells then die earlier.

Ketone bodies make immune system more powerful

The researchers also saw similar effects in another important group of immune cells, the killer T cells. "They too require ketone bodies to function well and effectively eliminate the virus," says Dr. Christian Bode, lecturer at the Department of Anesthesiology and Surgical Intensive Care Medicine at the University Hospital Bonn. Apparently, the ketone bodies cause a certain metabolic pathway to be activated in the immune cells. This not only ensures improved energy production, but also provides molecules needed for interferon production.

"Without an adequate supply of ketone bodies, on the other hand, the killer T cells and helper T cells show signs of exhaustion," Bode explains. "In this depleted state, they can no longer perform their function adequately." However, the researchers were able to revive the immune cells by placing sick mice on a ketogenic, or low-carbohydrate, diet or by administering ketone bodies directly. The animals were then better able to eliminate the virus. They also developed significantly less lung damage.

Hope for new treatment options

The results therefore also give hope for new treatment options. "It may be possible to increase the clout of the body's defenses by making specific dietary changes," Wilhelm says. "Further studies must now show whether this really works." The researchers expressly advise against self-experimentation with dietary supplements or diets, which could do more harm than good.

The new findings could also be relevant in other infections. In the medium term, they may even contribute to new strategies to help the body fight tumors.


Participating institutions and funding

In addition to the University Hospital and the University of Bonn, the TU Braunschweig and the University Hospitals of Hannover, Zurich, Nijmegen and Essen were involved in the study. The study was funded by the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), the European Research Council (ERC), and the Netherlands Organization for Scientific Research (NWO).


Publication

Fotios Karagiannis, Konrad Peukert, Laura Surace, Marcel Michla, Fabian Nikolka,
Mario Fox, Patricia Weiss, Caroline Feuerborn, Paul Maier, Susanne Schulz, Burcu Al, Benjamin Seeliger, Tobias Welte, Sascha David, Inge Grondman, Aline H de Nooijer, Peter Pickkers, Jan Lukas Kleiner, Marc Moritz Berger, Thorsten Brenner, Christian, Putensen, Bonn COVIMMUNE Consortium, Hiroki Kato, Natalio Garbi, Mihai G. Netea,Karsten Hiller, Katarzyna Placek, Christian Bode & Christoph Wilhelm; Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19; Nature; https://www.nature.com/articles/s41586-022-05128-8


Contact

Prof. Dr. Christoph Wilhelm

Institute for Clinical Chemistry and Clinical Pharmacology

University Hospital Bonn

Tel.: +49 (0)228/287-51721

E-Mail: cwilhelm(at)uni-bonn.de

Related news

Microglia interacting with T cells in the central nervous system of SPG15-deficient mice

News categories: Publication

Immune Cells Drive Congenital Paralysis Disease

Patients with spastic paraplegia type 15 develop movement disorders during adolescence that may ultimately require the use of a wheelchair. In the early stages of this rare hereditary disease the brain appears to play a major role by over-activating the immune system, as shown by a recent study published in the Journal of Experimental Medicine. The study was led by researchers at the University of Bonn and the German Center for Neurodegenerative Diseases (DZNE). These findings could also be relevant for Alzheimer's disease and other neurodegenerative conditions.
View entry
Scientists that contributed to the study

News categories: Publication

New way to prevent duodenal cancer

People with the hereditary disease familial adenomatous polyposis (FAP) have a greatly increased risk of developing a malignant tumor of the duodenum. Researchers at the University Hospital Bonn (UKB) and the Cluster of Excellence ImmunoSensation2 at the University of Bonn have now discovered a mechanism in the local immune system that can drive the development of cancer. They see this as a promising new approach to preventing duodenal carcinoma in people with FAP. The results have now been published in the journal "Nature Communications".
View entry
Kathrin Leppek Publication PM

News categories: Publication

Starting points for the control of protein synthesis

The research field of "cellular IRESes" lay dormant for decades, as there was no uniform standard of reliable methods for the clear characterization of these starting points for the ribosome-mediated control of gene expression. Researchers at the University Hospital Bonn (UKB) and the University of Bonn, in collaboration with Stanford University in California (USA), have now developed a toolbox as a new gold standard for this field. The results of their work have been published in The EMBO Journal.
View entry

Back to the news overview